Patents by Inventor John R. Stanley

John R. Stanley has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240086448
    Abstract: Embodiments of the present disclosure support systems and methods providing functionality for detecting the presence of cited with relationships in documents. In an aspect, a plurality of documents comprising legal citations is received and analyzed by one or more processors to detect cited with relationships within the documents. The plurality of documents may be analyzed to identify subsets of documents based on the legal citations and the cited with relationships. The cited with relationships may be identified and/or classified according to sets of proximity and/or contextual rules. In an aspect, metadata related to the cited with relationships may be generated and stored in a metadata database. In an aspect, metadata regarding cited with relationship may facilitate searching for documents having and/or identifying cited with relationships.
    Type: Application
    Filed: September 12, 2023
    Publication date: March 14, 2024
    Inventors: Sharon Ruth Stanley, Shelly Albaum, John Michael Engelhart, Steven R. Sidwell
  • Patent number: 8846867
    Abstract: This invention relates to compositions and methods for the use of anti-autoimmune reagents that specifically bind to anti-desmoglein antibodies, which are responsible for pemphigus foliaceus. In addition, the invention relates to methods and compositions for inhibiting the expression or function of a variable region of an anti-desmoglein (anti-Dsg) pathogenic autoantibody.
    Type: Grant
    Filed: May 9, 2008
    Date of Patent: September 30, 2014
    Assignee: The Trustees of the University of Pennsylvania
    Inventors: Aimee S. Payne, John R. Stanley, Donald L. Siegel, Jun Yamagami, Ken Ishii
  • Patent number: 8470323
    Abstract: The present invention relates to the use of non-pathogenic antibodies to deliver biologically-active proteins to specific cellular and sub-cellular sites. The invention also relates to the use of non-pathogenic antibodies to deliver biologically-active, non-protein molecules to specific cellular and sub-cellular sites.
    Type: Grant
    Filed: January 9, 2008
    Date of Patent: June 25, 2013
    Assignees: The Trustees of the University of Pennsylvania, Keio University
    Inventors: John R. Stanley, Donald L. Siegel, Amagai Masayuki
  • Patent number: 8298545
    Abstract: This invention relates to compositions and methods for the use of anti-autoimmune reagents that specifically bind to anti-desmoglein antibodies, which are responsible for both pemphigus vulgaris and pemphigus foliaceus. In addition, the invention relates to methods and compositions for inhibiting the expression or function of a variable region of an anti-desmoglein (anti-Dsg) pathogenic autoantibody.
    Type: Grant
    Filed: January 25, 2008
    Date of Patent: October 30, 2012
    Assignee: The Trustees of the University of Pennsylvania
    Inventors: Aimee S. Payne, John R. Stanley, Donald L. Siegel
  • Publication number: 20110200601
    Abstract: The present invention relates to the use of non-pathogenic antibodies to deliver biologically-active proteins to specific cellular and sub-cellular sites. The invention also relates to the use of non-pathogenic antibodies to deliver biologically-active, non-protein molecules to specific cellular and sub-cellular sites.
    Type: Application
    Filed: January 9, 2008
    Publication date: August 18, 2011
    Applicants: Trustees of The University of Pensylvania, Keio University
    Inventors: John R. Stanley, Donald L. Siegel, Amagai Masayuki
  • Publication number: 20110091449
    Abstract: This invention relates to compositions and methods for the use of anti-autoimmune reagents that specifically bind to anti-desmoglein antibodies, which are responsible for pemphigus foliaceus. In addition, the invention relates to methods and compositions for inhibiting the expression or function of a variable region of an anti-desmoglein (anti-Dsg) pathogenic autoantibody.
    Type: Application
    Filed: May 9, 2008
    Publication date: April 21, 2011
    Inventors: Aimee S. Payne, John R. Stanley, Donald L. Siegel, Ken Ishii
  • Publication number: 20100135948
    Abstract: This invention relates to compositions and methods for the use of anti-autoimmune reagents that specifically bind to anti-desmoglein antibodies, which are responsible for both pemphigus vulgaris and pemphigus foliaceus. In addition, the invention relates to methods and compositions for inhibiting the expression or function of a variable region of an anti-desmoglein (anti-Dsg) pathogenic autoantibody.
    Type: Application
    Filed: January 25, 2008
    Publication date: June 3, 2010
    Inventors: Aimee S. Payne, John R. Stanley, Donald L. Siegel